Dear Shareholders,
I’m pleased to share with you another edition of our investor newsletter, with a focus on our medical CT development programs.
We are entering one of the most significant periods in Micro-X's history. After more than a decade developing our carbon nanotube X-ray technology, we are now seeing that platform evolve into multiple CT imaging programs with global potential. From the first CNT emitter in 2018 through to today's human imaging study, portable full body CT development and new lung CT research, each milestone builds on the same core technology platform that differentiates Micro-X.
With continued pressure on health systems to deliver care under constrained budgets, ageing populations, and shrinking services in rural and remote areas, there is a strong push globally to find new solutions to meet the needs of communities. This is where Micro-X is uniquely positioned to deliver reliable miniaturised diagnostics, bringing critical medical imaging to the patient. Our company has a strong value proposition –our technology is unlike others and meets the critical needs of clinicians and their patients.
Last month we successfully took first human images using the Head CT scanner, marking the commencement of our human imaging trial at the Royal Melbourne Hospital. This is a significant technical milestone for the company as we progress the development of the future of CT technology. Importantly, this was a significant scientific feat, marking the first human to be imaged by a carbon nanotube cone beam CT.
Our Chief Operating Officer, and lead on the Head CT project, Anthony Skeats and some of the development team were in Melbourne for these first patient images to support the clinical researchers and witness the milestone. Since then, our team has been using these initial data sets to refine algorithms as we progress through the first phase of the pilot study.
Parallel to this, we have completed the test bench destined for the Royal Adelaide Hospital, which will be delivered around the time that we progress to the second phase of imaging at Royal Melbourne Hospital.
To coincide with the commencement of the pilot study, we are releasing a short video series looking at the development of our Head CT. The first two videos have been published and I invite you to visit our YouTube channel to watch the series as it continues to roll out.
.jpg)
While our hospital imaging study continues, work is also progressing on the next phase of Head CT deployment - bringing imaging directly into the ambulance. Our team has been working diligently to progress the design of the Head CT prototype for installation into a standard ambulance under the Australian Government Industry Growth Program funded project.
Last month we completed the second milestone under the grant, completing the design release review and the manufacture of early-stage prototypes of key aspects of the design to manage some of the project risks associated with the development of a novel prototype.
We will now progress the ambulance integration design in the lead up to the vehicle fitment review. As part of this, we have been fortunate to obtain a former ambulance which will provide us with important spatial information and the ability to review design aspects in real life as we move forward.
We are currently building the first full body CT prototype, using a series of our existing X-ray tubes and our solid state generator, adapted to facilitate tube switching. This prototype significantly de-risks the program and demonstrates our ability to manufacture one of the key enabling technologies required for future portable CT systems.
This will mark the completion of the first phase of our work with the US Government’s Advanced Research Projects Agency for Health (ARPA-H). Across the project, teams have been presenting prototypes for the five technical areas required to create a multi-functional, rugged electric vehicle platform that is equipped with advanced medical devices to deliver hospital-level care in rural communities. Micro-X is involved in Technical Area 4, the development of a rugged CT scanner that uses carbon nanotube CT for mobile care. The prototype is to be presented to ARPA-H later this year.
You may have seen our June announcement to the ASX about Micro-X’s involvement in the development of a laboratory lung CT scanner test bench, with a total of $1.9M awarded to project partners including $1.3M to Micro-X.
Under the research program, Micro-X is supplying the University of Sydney with a CT architecture using our existing technology platform, plus technical support, for integration into a lung imaging test bench. We have previously worked with the university on stage 1 of this project, which demonstrated the feasibility of a stationary CNT architecture for lung CT in a laboratory setting. This next phase will see the development of a proof-of-concept test bench for early detection of lung cancer. It is exciting work that partners with the University of Sydney’s quantum researchers to examine possibilities for a commercial product.
What excites me most is that every one of these programs builds from the same technology platform our team has spent years developing. Seeing that investment begin to translate into clinical studies, government partnerships and multiple commercial opportunities reinforces our belief that Micro-X is creating not only something genuinely different, but something of significant real value.
Keep an eye out for an invitation to attend our 2026 Investor Open Day, to be held in the coming months. We look forward to hosting you at our Tonsley site and showing you the latest developments in our world-leading technology.
As always, I thank you for your continued support for Micro-X as we push the boundaries of science and technology to deliver world-leading products that better lives.
Kingsley Hall
Chief Executive Officer
Read about stroke trials from the Australian Stroke Alliance
Advancing X-ray Imaging with High Performance Connectivity
Herald Sun - New Australian medical breakthroughs and technology changing healthcare
Aunt Minnie - Micro-X enters new $1.9M research partnership
The Australian - Micro-X captures first human images with Head CT
Manufacturing Monthly - Our manufacturing future - agile, modular and biotech driven
Micro-X provides shareholders with an update on the Head CT human imaging trial, portable Full Body CT development, Lung CT research and the company's carbon nanotube imaging technology platform.
As healthcare delivery continues to shift toward faster, more decentralised models of care, Mobile Digital Radiography (DR) Systems are becoming increasingly important across emergency departments, intensive care units, operating theatres and remote care settings. Hospitals evaluating a new Mobile DR system are no longer considering image quality alone — they are assessing workflow efficiency, operational reliability, integration capabilities and long-term cost of ownership.
At Micro-X, a determination to push beyond boundaries and challenge limits has heralded the creation of world-leading cold cathode X-ray and CT technology. Hear about our Independence Day and our push to continue driving NEX Technology into new and groundbreaking future advancements.
Micro-X creates revolutionary X-ray technology to better lives.
Our PurposeFind out how Micro-X is creating new opportunities for industries across the world.
Find out moreThey’re the visionaries and innovators behind our X-ray technology, products, culture and ethos.
Meet the team
